Structural damage in diabetic nephropathy is associated with TNF-α system activity

Acta Diabetologica

Volumn 49, Issue 4, 2012, Pages 301-305

  Fernández Real, Jose Manuel ^a   Vendrell, Joan ^b   García, Isabel ^a   Ricart, Wifredo ^a   Valles, Martí ^a  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

Diabetic nephropathy; Inflammation; Renal histology; TNF system; Type 2 diabetes

Indexed keywords

IOTALAMIC ACID I 125; SOLUBLE TUMOR NECROSIS FACTOR ALPHA RECEPTOR 1; SOLUBLE TUMOR NECROSIS FACTOR ALPHA RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; GLOMERULUS FILTRATION RATE; HISTOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY HYPERTROPHY; KIDNEY STRUCTURE; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL;

ADULT; ALBUMINURIA; CROSS-SECTIONAL STUDIES; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84864937226     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-011-0349-y     Document Type: Article

References (27)

1. Parving HH, Osterby R, Anderson PW, Hsuch WA (1996) Diabetic nephropathy. In: Brenner BM (ed) The kidney. Saunders, Philadelphia, pp 1864-1922
2. Hasegawa G, Nakano K, Sawada M et al (1991) Possible tole of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy. Kidney Int 40:1007-1012
3. Vlassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A (1988) Cachectin/TNF and IL-1 induced by glucose modified proteins: role in normal tissue remodelling. Science 240:1546-1548
4. Baund L, Oudinet JP, Marcelle B et al (1989) Production of tumor necrosis factor by rat mesangial cells in response to bacterial lipopolysaccharide. Kidney Int 35:1111-1118
5. Navarro JF, Mora C, Rivero A et al (1999) Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: effects of pentoxifylline administration. Am J Kidney Dis 33:458-463
6. Ortiz A, Gonzalez-Cuadrado S, Bustos C et al (1995) Tumor necrosis factor as a mediator of glomerular damage. J Nephrol 8:27-34
7. Ng DP, Fukushima M, Tai BC et al (2008) Reduced GFR and albuminuria in Chinese type 2 diabetes mellitus patients are both independently associated with activation of the TNF-alpha system. Diabetologia 51:2318-2324
8. Fernandez-Real JM, Broch M, Ricart W et al (1998) Plasma levels of the soluble fraction of tumor necrosis factor receptor-2 and insulin resistance. Diabetes 47:1757-1762
9. Adamska A, Nikolajuk A, Karczewska-Kupczewska M et al (2011) Relationships between serum adiponectin and soluble TNF-a receptors and glucose and lipid oxidation in lean and obese subjects. Acta Diabetol (Epub ahead of print)
10. Wu W, Wang M, Sun Z, Wang X, Miao J, Zheng Z (2011) The predictive value of TNF-alpha and IL-6 and the incidence of macrovascular complications in patients with type 2 diabetes. Acta Diabetol (Epub ahead of print)
11. Blank SE, Johnson EC, Weeks DK, Wysham CH (2010) Circulating dendritic cell number and intracellular TNF-alpha production in women with type 2 diabetes. Acta Diabetol (Epub ahead of print)
12. Dogrul A, Gul H, Yesilyurt O, Ulas UH, Yildiz O (2011) Systemic and spinal administration of etanercept, a tumor necrosis factor alpha inhibitor, blocks tactile allodynia in diabetic mice. Acta Diabetol 48:135-142
13. Pfeilschifter J, Pignat W, Vosbeck K, Märki F (1989) Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat mesangial cells. Biochem Biophys Res Commun 159:385-394
14. Royall JA, Berkow RL, Beckman JS et al (1989) Tumor necrosis factor and interleukin 1 increase vascular endothelial permeability. Am J Physiol 257:L399-L410
15. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D (1992) Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 175:323-329
16. Nelson RG, Bennett PH, Beck GJ et al (1996) Development and progression of renal disease in Pima Indians with non insulin dependent diabetes mellitus. N Engl J Med 335:1636-1642
17. Magee GM, Bilous RW, Cardwell CR, Hunter SJ, Kee F, Fogarty DG (2009) Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia 52:691-697
18. DiPetrillo K, Coutermarsh B, Gesek FA (2003) Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes. Am J Physiol Renal Physiol 284:F113-F121
19. Smith CA, Farrah T, Goodwin RG (1994) The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death. Cell 76:959-962
20. Sheikh MS, Huang Y (2003) Death receptor activation complexes: it takes two to activate TNF receptor 1. Cell Cycle 2:550-552
21. Hofmann MA, Schiekofer S, Isermann B et al (1999) Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-jB. Diabetologia 42:222-232
22. Satriano J, Schlöndorff D (1994) Activation and attenuation of transcription factor NF-jB in mouse glomerular mesangial cells in response to tumor necrosis factor-a, immunoglobulin G and adenosine 30 50-cyclic monophosphate. J Clin Invest 94:1629-1636
23. Hruby AW, Shirota K, Jothy S, Lowry RP (1991) Antiserum against tumor necrosis factor-alpha and a protease inhibitor reduce glomerular injury. Kidney Int 40:43-51
24. Moriwaki Y, Inokuchi T, Yamamoto A et al (2007) Effect of TNF-alpha inhibition on urinary albumin excretion in experimental diabetic rats. Acta Diabetol 44:215-218
25. Menghini R, Menini S, Amoruso R et al (2009) Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice. Gastroenterology 136:663-672
26. Serino M, Menghini R, Fiorentino L et al (2007) Mice heterozygous for tumor necrosis factor-alpha converting enzyme are protected from obesity-induced insulin resistance and diabetes. Diabetes 56:2541-2546
27. Guerrero-Romero F, Rodriguez-Moran M, Paniagua-Sierra JR et al (1995) Pentoxifylline reduces proteinuria in insulin-dependent and non insulin-dependent diabetic patients. Clin Nephrol 43:116-121